Milestone Event Milestone Payment. [***] [***]
Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**]Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]
Milestone Event Milestone Payment. 1. The first time in which worldwide, aggregate Net Sales in a calendar year of [**] Engineered T-Cell Products exceeds $[**] [**]
Milestone Event Milestone Payment. 6 First time Annual Net Sales of all Products exceed $[***] $[***]
Milestone Event Milestone Payment. (i) First dosing of a subject in a Phase I Study of a Licensed Product $ 10,000,000 [***] [***] [***] [***] [***] [***] [***] [***]
Milestone Event Milestone Payment. 5.3.1 The first approval by the FDA/CVM of a MUMS indication (or the equivalent in a Major Market) for each Non-CRO-Product; $ 50,000
Milestone Event Milestone Payment. Initial Milestone Events
Milestone Event Milestone Payment. Annual Net Sales of a given Product in Territory first reach [***] [*** ] Annual Net Sales of a given Product in Territory first reach [***] [*** ] The above milestone payments are payable only once for a particular Product, and shall be payable on a Product-by-Product basis for each Product to reach the indicated annual Net Sales threshold. The payments payable by BMS to Ambrx under this Section 8.3 shall be paid within sixty (60) days following the end of the applicable Calendar Year.
Milestone Event Milestone Payment. Initiation of first GLP Toxicology Study of a Product under the applicable Post-Effective Date Program [*]
